Senseonics Holdings, Inc. (NYSE:SENS) Eversense 365 Commercial Update Conference
Company Participants
Tim Goodnow – President, CEO & Director
Frederick Sullivan – CFO, Secretary & Treasurer
Conference Call Participants
Jeremy Feffer – Lifesci Advisors, LLC
Brian Hansen – Ascensia Diabetes Care Us Inc.
Matthew Miksic – Barclays Bank PLC, Research Division
Anthony Petrone – Mizuho Securities USA LLC, Research Division
Joshua Jennings – TD Cowen, Research Division
Benjamin Haynor – Lake Street Capital Markets, LLC, Research Division
Jayson Bedford – Raymond James & Associates, Inc., Research Division
Xun Lee – H.C. Wainwright & Co, LLC, Research Division
Presentation
Operator
Good day, everyone, and welcome to the Eversense 365 Commercial Update Call. [Operator Instructions] Please note, this call is being recorded. [Operator Instructions] It is now my pleasure to turn the conference over to Jeremy Feffer, Investor Relations. Please go ahead.
Jeremy Feffer
Managing Director
Thank you. This is Jeremy Feffer from Lifesci Advisors. Before we begin today, let me remind you that the company’s remarks include forward-looking statements. These statements reflect management’s expectations about future events, operating plans, regulatory matters, product enhancements, company performance and other matters that speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties.
A list of the factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is detailed under Risk Factors and elsewhere in our annual report on Form 10-K for the year ended December 31, 2024, and our 10-Qs and our other reports filed with the SEC. These documents are available on the Investor Relations section of our website at www.senseonics.com. We undertake no obligation to update publicly or revise these forward-looking statements for any reason, except as required by law.
Joining me today from Senseonics are Tim Goodnow, President and Chief Executive
Read the full article here